Research Archive — Page 4 of 133

April 7, 2026

Sickle cell disease heightens risk for precancerous blood disorder

These findings shed light on disruptions in normal blood cell development (hematopoiesis) that may be shared by sickle cell disease and clonal hematopoiesis.

April 6, 2026

Julia Bohannon elected president-elect of Shock Society

Badly burned as a child, Bohannon is committed to developing better therapies for burn patients.

April 3, 2026

Vanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment

“These antibodies hold significant promise to be used in people who are at risk of measles, but who cannot respond to the measles vaccine due to their weakened immune systems,” said James Crowe Jr., MD, whose research team isolated the human monoclonal antibodies.

April 2, 2026

Study identifies potential noninvasive blood marker for Crohn’s disease activity

One immune cell signaling molecule was increased in active versus inactive Crohn’s disease in both endoscopic and histologic activity assessments, suggesting it could serve as a potential noninvasive marker of disease activity.

March 27, 2026

2026 REDCap Fest recordings available online

Videos and slides from REDCap Fest 2026, held online March 4-6, are available for viewing by members of the Vanderbilt and Meharry Medical College community.

March 26, 2026

Six Vanderbilt faculty named honorary fellows of prestigious scientific society

The 2025 fellows have been invited to the annual AAAS Fellows Forum May 29 in Washington, D.C.